Terms: = Head and neck cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
11 results:
1. Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma.
Wang Z; Cheng Z; Lu S; Chard Dunmall LS; Wang J; Guo Y; Wang Y
Front Immunol; 2022; 13():896627. PubMed ID: 35812448
[TBL] [Abstract] [Full Text] [Related]
2. Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography.
Gong RX; Gong YP; Yang J; Wei T; Li-Ling J; Zhu JQ
Genet Mol Res; 2013 Oct; 12(4):4990-7. PubMed ID: 24301760
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions.
Hamadah O; Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2010 Oct; 48(7):503-6. PubMed ID: 19800717
[TBL] [Abstract] [Full Text] [Related]
4. [Prognostic significance of cyclin D1 and cyclin B expression in laryngeal squamous cell carcinomas treated with radiotherapy].
Dupla D; Fraczek M; Krecicki T; Woźniak Z
Otolaryngol Pol; 2009; 63(2):136-40. PubMed ID: 19681484
[TBL] [Abstract] [Full Text] [Related]
5. FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck.
Taylor RJ; Chan SL; Wood A; Voskens CJ; Wolf JS; Lin W; Chapoval A; Schulze DH; Tian G; Strome SE
Cancer Immunol Immunother; 2009 Jul; 58(7):997-1006. PubMed ID: 18979096
[TBL] [Abstract] [Full Text] [Related]
6. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
[TBL] [Abstract] [Full Text] [Related]
7. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification.
Pulcrano M; Boukheris H; Talbot M; Caillou B; Dupuy C; Virion A; De Vathaire F; Schlumberger M
Thyroid; 2007 Jul; 17(7):639-46. PubMed ID: 17696834
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classification.
Takeno S; Noguchi T; Takahashi Y; Fumoto S; Shibata T; Kawahara K
Ann Surg Oncol; 2007 Apr; 14(4):1431-8. PubMed ID: 17260107
[TBL] [Abstract] [Full Text] [Related]
9. Cutaneous lymphoid hyperplasia presenting as a solitary facial nodule: clinical, histopathological, immunophenotypical, and molecular studies.
Bergman R; Khamaysi Z; Sahar D; Ben-Arieh Y
Arch Dermatol; 2006 Dec; 142(12):1561-6. PubMed ID: 17178981
[TBL] [Abstract] [Full Text] [Related]
10. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
[TBL] [Abstract] [Full Text] [Related]
11. Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma?
Schaap J; Eustatia-Rutten CF; Stokkel M; Links TP; Diamant M; van der Velde EA; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2002 Jul; 57(1):117-24. PubMed ID: 12100079
[TBL] [Abstract] [Full Text] [Related]
